A detailed history of Tufton Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Tufton Capital Management holds 9,672 shares of PFE stock, worth $253,116. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,672
Previous 9,053 6.84%
Holding current value
$253,116
Previous $253,000 10.28%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $17,146 - $19,430
619 Added 6.84%
9,672 $279,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $18,123 - $20,811
-700 Reduced 7.18%
9,053 $251,000
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $9,798 - $12,727
-375 Reduced 3.7%
9,753 $280,000
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $8,126 - $9,402
-225 Reduced 2.17%
10,128 $371,000
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $82,247 - $107,365
1,970 Added 23.5%
10,353 $0
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $58,880 - $72,960
1,287 Added 18.14%
8,383 $433,000
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $49,790 - $73,806
1,205 Added 20.45%
7,096 $419,000
Q3 2021

Oct 21, 2021

SELL
$39.25 - $50.42 $8,281 - $10,638
-211 Reduced 3.46%
5,891 $253,000
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $17,919 - $20,299
499 Added 8.91%
6,102 $238,000
Q3 2020

Oct 23, 2020

BUY
$31.75 - $37.25 $177,895 - $208,711
5,603 New
5,603 $205,000
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $154,962 - $221,408
-5,733 Closed
0 $0
Q3 2019

Oct 25, 2019

SELL
$32.49 - $42.13 $18,356 - $23,803
-565 Reduced 8.97%
5,733 $205,000
Q2 2019

Jul 26, 2019

BUY
$36.98 - $41.52 $1,109 - $1,245
30 Added 0.48%
6,298 $272,000
Q1 2019

Apr 29, 2019

BUY
$37.5 - $41.2 $38,287 - $42,065
1,021 Added 19.46%
6,268 $266,000
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $1,923 - $2,193
-50 Reduced 0.94%
5,247 $229,000
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $32,436 - $39,343
-941 Reduced 15.08%
5,297 $233,000
Q2 2018

Aug 06, 2018

SELL
$32.98 - $35.16 $3,297 - $3,515
-100 Reduced 1.58%
6,238 $226,000
Q1 2018

Apr 23, 2018

SELL
$31.91 - $37.02 $5,807 - $6,737
-182 Reduced 2.79%
6,338 $224,000
Q4 2017

Jan 26, 2018

BUY
$33.26 - $35.29 $2,494 - $2,646
75 Added 1.16%
6,520 $236,000
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $199,795 - $220,096
6,445
6,445 $230,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tufton Capital Management Portfolio

Follow Tufton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.